Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Eduardo Perez

Interventional Cardiology Gainesville, FL Medical Doctor

NPI 1326400508 CMS profile 4218652

1600 Sw Archer Road, Gainesville, FL 32610

Open in the dashboard

General payments

$47,080

411 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Eduardo Perez of Gainesville, FL is reported in the CMS Open Payments database as having received $47,080 across 411 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,074 32
2024 General $2,729 99
2023 General $26,922 95
2022 General $2,724 26
2021 General $9,520 134
2020 General $335 12
2019 General $776 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Eduardo Perez
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Eduardo Perez were reported at $4,074. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Eduardo Perez Interventional Cardiology median Middle half National median
2019 $776 $1,097 $329–$3,048 $163
2020 $335 $473 $161–$1,480 $114
2021 $9,520 $677 $233–$1,827 $132
2022 $2,724 $978 $333–$2,724 $149
2023 $26,922 $1,136 $382–$2,986 $160
2024 $2,729 $1,181 $395–$3,326 $164
2025 $4,074 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $26,600 165 payments
  2. Abbott Laboratories $10,711 119 payments
  3. Boston Scientific Corporation $2,384 31 payments
  4. Biotronik Inc. $2,355 15 payments
  5. Edwards Lifesciences Corporation $1,978 38 payments
  6. W. L. Gore & Associates, Inc. $1,381 7 payments
  7. Pfizer Inc. $261 9 payments
  8. Amgen Inc. $164 7 payments
  9. Reflow Medical Inc $163 1 payment
  10. Cardiva Medical, Inc. $133 3 payments
  11. Other $950 16 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Grant $22,300 2 payments
  2. Food and Beverage $12,975 355 payments
  3. Travel and Lodging $11,335 50 payments
  4. Education $470 4 payments
Products named General payments · program years 2019–2025
  1. COREVALVE EVOLUT R $25,197 124 payments
  2. EnSite Precision Cardiac Mapping System $4,045 37 payments
  3. Rivacor $2,355 15 payments
  4. Edora $2,355 15 payments
  5. Acticor $2,355 15 payments
  6. TRICLIP $2,161 15 payments
  7. Solia $1,831 14 payments
  8. BioMonitor $1,831 14 payments
  9. HeartMate Touch $1,462 14 payments
  10. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $1,319 16 payments
  11. Other $10,795 172 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 14 billing codes

Paid by Medicare

$4,449

Medicare's payments for the services billed

Medicare patients

19

Average age 71

Services billed

36

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 74%
Diabetes 63%
Chronic kidney disease 58%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

411 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record